144 related articles for article (PubMed ID: 22676864)
1. Is the end of chronic hepatitis C virus infection in sight?
McCaughan GW
Med J Aust; 2012 Jun; 196(10):614. PubMed ID: 22676864
[No Abstract] [Full Text] [Related]
2. [Treatment of hepatitis C infection: towards eradication of chronic virus].
Ahola T; Kaukinen P
Duodecim; 2012; 128(18):1911-7. PubMed ID: 23088003
[TBL] [Abstract][Full Text] [Related]
3. [Advance in the management of the difficult-to-treat patients with chronic hepatitis C].
Xie Y; Li MH
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):484-6. PubMed ID: 19912677
[No Abstract] [Full Text] [Related]
4. New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye.
Dusheiko G; Wedemeyer H
Gut; 2012 Dec; 61(12):1647-52. PubMed ID: 22936671
[No Abstract] [Full Text] [Related]
5. Treating chronic hepatitis C in recovering opiate addicts: yes, we can.
Kreek MJ; Talal AH; Piccolo P
Dig Liver Dis; 2009 Apr; 41(4):308-10. PubMed ID: 19233749
[No Abstract] [Full Text] [Related]
6. Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia.
Hellard ME; Jenkinson R; Higgs P; Stoové MA; Sacks-Davis R; Gold J; Hickman M; Vickerman P; Martin NK
Med J Aust; 2012 Jun; 196(10):638-41. PubMed ID: 22676879
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
Grebely J; Dalgard O; Cunningham EB; Hajarizadeh B; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Amin J; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Hellard M; Bruneau J; Midgard H; Bourgeois S; Staehelin C; Dore GJ;
Int J Drug Policy; 2017 Sep; 47():177-186. PubMed ID: 28624134
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation.
Reddy KR; Everson GT
Hepatology; 2013 Sep; 58(3):1181-4. PubMed ID: 23908010
[No Abstract] [Full Text] [Related]
9. The dilemma for patients with chronic hepatitis C: treat now or warehouse?
Alberti A; Colombo M; Craxì A; Rizzetto M
Dig Liver Dis; 2014 Jan; 46(1):27-9. PubMed ID: 24268949
[No Abstract] [Full Text] [Related]
10. Clinical practice. Chronic hepatitis C infection.
Rosen HR
N Engl J Med; 2011 Jun; 364(25):2429-38. PubMed ID: 21696309
[No Abstract] [Full Text] [Related]
11. [Therapy of chronic hepatitis C].
Schaffstein S; Rampini SK; Müllhaupt B
Praxis (Bern 1994); 2014 Apr; 103(8):423-36. PubMed ID: 24713377
[No Abstract] [Full Text] [Related]
12. [Treatment for chronic hepatitis C, more opportunity, more challenge].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676
[No Abstract] [Full Text] [Related]
13. [Pegylated interferon α-2a and ribavirin antiviral therapy efficacy for treating chronic hepatitis C and its effects on psychological status of patients].
An J; Qiao J; Ni W
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):772-3. PubMed ID: 25558497
[No Abstract] [Full Text] [Related]
14. [Treatment of infection due to hepatitis C virus in haemodialysis].
Hidalgo-Collazos P; Marín-Ventura L; Sánchez R; García-López L; Criado-Illana MT
Nefrologia; 2014; 34(1):132-3. PubMed ID: 24463875
[No Abstract] [Full Text] [Related]
15. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C.
Hadziyannis SJ; Sevastianos V
Aliment Pharmacol Ther; 2013 Feb; 37(4):491. PubMed ID: 23336678
[No Abstract] [Full Text] [Related]
16. The end of the beginning for hepatitis C treatment.
Dieterich D
Hepatology; 2012 Mar; 55(3):664-5. PubMed ID: 22174100
[No Abstract] [Full Text] [Related]
17. The comparison of chronic hepatitis C treatment outcome between intravenous drug users and non-intravenous drug users.
Bojovic K; Simonovic J; Katanic N; Milosevic I; Pesic I; Delic D; Svirtlih N; Jevtovic DJ
Biomed Pharmacother; 2013 Jul; 67(6):517-20. PubMed ID: 23639229
[TBL] [Abstract][Full Text] [Related]
18. The changing therapeutic landscape for hepatitis C.
Dore GJ
Med J Aust; 2012 Jun; 196(10):629-32. PubMed ID: 22676877
[TBL] [Abstract][Full Text] [Related]
19. [Chronic C virus infection management].
García González N; Prieto Valtueña J
Rev Clin Esp; 2003 Sep; 203(9):443-4. PubMed ID: 14563259
[No Abstract] [Full Text] [Related]
20. Chronic hepatitis C virus infection in 2013--quo vadis?
Prelipcean CC; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):7-10. PubMed ID: 24505885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
